PAL
Click for more information
0.00% 29.5¢ palla pharma limited

News: PAL Palla Pharma Enters Into New Multi‐Year Supply Agreement With A European Customer

  1. Hot News
    191,609 Posts.
    lightbulb Created with Sketch. 2809
    clock Created with Sketch.
    23/07/19
    11:00
    Post #: 39646051

    July 23 (Reuters) - Palla Pharma Ltd (PAL) :

    • ENTERS INTO A NEW MULTI‐YEAR SUPPLY AGREEMENT WITH A EUROPEAN CUSTOMER
    • 1H 2019 REVENUE IS EXPECTED TO EXCEED MAY GUIDANCE OF $24 ‐ $26 MILLION
    • PAL EXPECTS TO REPORT A MODEST, MAIDEN HALF YEAR OPERATING EBITDA PROFIT
    • REITERATE EXPECTATIONS OF A MODEST OPERATING EBITDA PROFIT FOR 1H 2019
    • TOTAL CONTRACT REVENUE VALUE OF NOT LESS THAN US$25 MILLION
    • CONFIRM ESTIMATE FOR FY 2019 REVENUE OF OVER $60 MILLION

    Source text : http://bit.ly/2JZsPJM

    (([email protected];))

    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MM1 Geochemical work at Newington picks up gold and copper anomalies for Midas
right-arrow Created with Sketch.
IGO IGO kicks off earn-in copper drilling on-site Encounter's Yeneena play as it adopts new identity
right-arrow Created with Sketch.
FMG Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%
right-arrow Created with Sketch.
HRZ Horizon firms up ore reserve for Boorara ahead of FY25 Q1 development decision
right-arrow Created with Sketch.
MND Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
right-arrow Created with Sketch.
BGL Bellevue aims for 45% production increase by FY 2028, announces $150M placement
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.